20 completed, 4 terminated, 1 suspended, 1 unknown. 12 Phase 3, 9 Phase 2, 3 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 9, Terminated 3 |
| Phase 2 | 9 | Completed 8, Terminated 1 |
| Phase 4 | 3 | Completed 1, Suspended 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow ZARS Pharma Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In Children, Does Using a Synera Patch Decrease Pain When Injecting Propofol at Anesthesia Induction? lidocaine/tetracaine transdermal patch (NDC 43469-864-01), Gebauer's Ethyl Chloride - Pain on Propofol IV Injection | Phase 4 | Unknown | The University of Texas Health Science Center, Houston | 80 | 2012-04-01 | 2012-04-12 |
| Epidemiology of Osteoarthritis (OA) Pain Osteoarthritis | Completed | Northwestern University | 86 | 2012-03-01 | 2018-03-29 | |
| Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points Heated lidocaine/tetracaine patch - Myofascial Pain Syndromes | Phase 2 | Completed | ZARS Pharma Inc. | 20 | 2010-06-01 | 2012-03-16 |
| Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy Heated Lidocaine and Tetracaine Patch - Patellar Tendinopathy | Phase 2 | Completed | ZARS Pharma Inc. | 13 | 2010-06-01 | 2012-03-16 |
| Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome Heated lidocaine and tetracaine topical patch - Shoulder Impingement Syndrome | Phase 2 | Completed | ZARS Pharma Inc. | 20 | 2010-03-01 | 2012-03-16 |
| Pharmacokinetic Study of Synera in Healthy Volunteers Synera - Healthy | Phase 1 | Completed | ZARS Pharma Inc. | 12 | 2010-02-01 | 2012-10-17 |
| Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome Synera (lidocaine 70 mg and tetracaine 70 mg) topical patch - Carpal Tunnel Syndrome | Phase 2 | Completed | ZARS Pharma Inc. | 24 | 2009-09-01 | 2012-03-16 |
| Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis Triamcinolone Acetonide (TAC) DuraPeel, Placebo DuraPeel - Hand Dermatoses | Phase 2 | Completed | ZARS Pharma Inc. | 56 | 2009-04-01 | 2012-03-16 |
| Pharmacokinetic Study of Synera™ in Neonates and Infants lidocaine 70mg and tetracaine 70mg topical patch - Pain | Phase 4 | Suspended | ZARS Pharma Inc. | 11 | 2008-09-01 | 2012-03-23 |
| Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN) lidocaine and tetracaine cream 7%/7%, Placebo - Postherpetic Neuralgia | Phase 2 | Completed | ZARS Pharma Inc. | 23 | 2008-01-01 | 2012-03-29 |
| A Phase 3 Study to Evaluate the Long-Term Safety of ThermoProfen™ in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee. ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System) - Osteoarthritis | Phase 3 | Terminated | ZARS Pharma Inc. | 179 | 2007-09-01 | 2012-03-16 |
| Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System), Placebo Matrix/CHADD Patch, Ketoprofen matrix/placebo CHADD Patch - Osteoarthritis | Phase 3 | Completed | ZARS Pharma Inc. | 679 | 2007-06-01 | 2012-05-30 |
| Evaluate the Depth and Duration of Anesthesia Synera™ Topical Patch (70 mg lidocaine/70 mg tetracaine), Placebo Patch - Pain | Phase 4 | Completed | ZARS Pharma Inc. | 25 | 2006-12-01 | 2009-05-01 |
| Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain Matrix Transdermal Fentanyl/CHADD Drug Delivery System, Placebo Patch - Pain | Phase 2 | Terminated | ZARS Pharma Inc. | 109 | 2006-01-01 | 2012-06-05 |
| Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain Fentanyl Transdermal Matrix Patch ZR-02-01 - Pain, Cancer | Phase 3 | Terminated | ZARS Pharma Inc. | 24 | 2005-08-01 | 2012-06-05 |
| Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain Fentanyl Transdermal Matrix Patch ZR-02-01 - Pain | Phase 3 | Terminated | ZARS Pharma Inc. | 105 | 2005-07-01 | 2012-06-05 |
| S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%), Placebo Peel - Pain | Phase 3 | Completed | ZARS Pharma Inc. | 80 | 2005-06-01 | 2012-06-05 |
| S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%), Placebo Peel - Pain | Phase 3 | Completed | ZARS Pharma Inc. | 81 | 2005-06-01 | 2012-06-06 |
| S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%), Placebo Peel - Pain | Phase 3 | Completed | ZARS Pharma Inc. | 54 | 2005-06-01 | 2012-06-05 |
| Duration of Skin Numbing Effect Created by the S-Caine™ Peel S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%) - Pain | Phase 3 | Completed | ZARS Pharma Inc. | 40 | 2005-06-01 | 2012-06-05 |
Showing 20 of 26. Sign in to see all of them.
Pain (21) · Osteoarthritis (5) · Chronic Pain (4) · Agnosia (1) · Cancer Pain (1) · Carpal Tunnel Syndrome (1) · Hand Dermatoses (1) · Motor Activity (1) · Myofascial Pain Syndromes (1) · Neoplasms (1) · Neuralgia, Postherpetic (1) · Osteoarthritis, Knee (1) · Shoulder Impingement Syndrome (1)
Lidocaine (12) · Tetracaine (3) · Transdermal Patch (3) · Ethyl Chloride (1) · Triamcinolone Acetonide (1)
United States (26)
Richard Rauck, MD (2) · Tina Alster, MD (2) · Alicia Barba, MD (1) · Andrew Wiznia, MD (1) · Anthony R Godfrey, Pharm.D. (1) · Daniel Piacquadio, MD (1) · David Borenstein, MD (1) · Frank Farmer, Jr, MD (1) · H F Farmer, MD (1) · Henry Goitz, MD (1) · Joseph A Markenson, MD (1) · Larry Gilderman, DO (1) · Lynn R Webster, MD (1) · Michael Gold, MD (1)